The largest community of pharma leaders

Abzena Announces 14-Month Cell Line to Phase 1 GMP Service and Appointment of Shahram Katousian as Head of Biologics Manufacturing

SAN DIEGO–(BUSINESS WIRE)–Abzena, the leading biotherapeutics target to GMP partner research organization (PRO) announced an accelerated program to IND. This reduces timeline from stable pool to GMP down to 14 months. The timeline is achieved by use of single project team with experienced leadership, overlapping of operational activities, internal technology transfer within Abzena, proprietary technologies and scalable single use bioreactors. Abzena builds on a track record of 10….


Recent Articles